Cardioselective beta-blockers for reversible airway disease.
about
Cardioselective beta-blockers for chronic obstructive pulmonary diseaseUse of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBeta-blocker use and COPD mortality: a systematic review and meta-analysisAn integrative review of systematic reviews related to the management of breathlessness in respiratory illnessesInverse agonism and its therapeutic significance.Changes in rates of beta-blocker use in community hospital patients with acute myocardial infarction.High blood pressure, antihypertensive medication and lung function in a general adult populationBucindolol: a pharmacogenomic perspective on its use in chronic heart failureBeta-blockers: friend or foe in asthma?Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditionsAgonizing over agonism: should asthmatics turn their beta-receptors on or off?Management of asthma in adultsSpirometry reference values in the Brazilian populationThe Real Role of β-Blockers in Daily Cardiovascular Therapy.Temporal Trends in Treatment and Outcomes of Acute Myocardial Infarction in Patients With Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Observational Study.Considerations of prescribers and pharmacists for the use of non-selective β-blockers in asthma and COPD patients: An explorative study.
P2860
Q24245649-37C7094F-0692-4D59-A375-173E93E81295Q24245649-388BA562-F422-472E-AEE6-1421A107DCDAQ24658205-FD29741B-F028-4189-9C78-4966F6F2EC2CQ27026866-5A12BBA7-5A48-4AB6-98B2-8139EB199221Q33766956-679B3774-3F06-4861-86B8-50998299EA91Q34226789-F73E35E2-8B32-4A6D-ABA0-3F27FF50946AQ34733754-78AB382A-B250-4E06-83B1-ACBE61E6B367Q34961913-EB6EBA7E-D7A2-4F31-A17E-DBB66774EE00Q35117742-362A28FE-182A-4B76-8DF2-2EDAC9537FC4Q37006857-64B8EFA5-D60D-4B09-8BE5-F193725366F0Q37082599-4D51542B-B6DB-4A61-9888-911F9FDC4E00Q37114730-9F79757E-A74C-42F0-BD0B-AC425665EACEQ37460865-069092FA-ACF4-4C3C-B21C-1C815882C5A7Q37735778-ADF0A1D6-5BC4-4207-9B16-A0554D29FBACQ39208428-4438D771-2688-475E-9259-CE50B77F32C7Q41103839-1B2B6E49-9FF3-4FAA-8731-A5D29AD3D635Q48272068-626B7061-2333-424A-962E-0FF08C4784DD
P2860
Cardioselective beta-blockers for reversible airway disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cardioselective beta-blockers for reversible airway disease.
@ast
Cardioselective beta-blockers for reversible airway disease.
@en
Cardioselective beta-blockers for reversible airway disease.
@nl
type
label
Cardioselective beta-blockers for reversible airway disease.
@ast
Cardioselective beta-blockers for reversible airway disease.
@en
Cardioselective beta-blockers for reversible airway disease.
@nl
altLabel
Cardioselective beta-blocker use in patients with reversible airway disease.
@ast
Cardioselective beta-blocker use in patients with reversible airway disease.
@en
Cardioselective beta-blocker use in patients with reversible airway disease.
@nl
Cardioselective beta-blockers for reversible airway disease
@en
Cardioselective beta-blockers for reversible airway disease
@nl
prefLabel
Cardioselective beta-blockers for reversible airway disease.
@ast
Cardioselective beta-blockers for reversible airway disease.
@en
Cardioselective beta-blockers for reversible airway disease.
@nl
P1476
P2093
P2860
P433
P577
P698
P1476
Cardioselective beta-blocker use in patients with reversible airway disease.
@en
Cardioselective beta-blockers for reversible airway disease
@en
Cardioselective beta-blockers for reversible airway disease.
@en
P2093
E Salpeter
S Salpeter
T Ormiston
P2860
P304
P356
10.1002/14651858.CD002992
P407
P433
P577
2001-01-01T00:00:00Z
2002-01-01T00:00:00Z